| [1] |
HUANG Huiqi, WU Qiuyuan, ZHANG Kun, LI Peixian, XIONG Yaming, YE Guolin, ZHOU Dan.
Research on the anti-tumor mechanism of toosendanin combined with olaparib in triple negative breast cancer
[J]. Tianjin Medical Journal, 2025, 53(9): 897-902.
|
| [2] |
XIE Pengliang, ZHENG Lufang, LI Yan, ZHENG Yanjin, BAI Lingdi, ZHAO Xia, LU Yinglong.
Correlation of vascular endothelial growth factor with the severity of cystoid macular edema in patients with diabetes mellitus
[J]. Tianjin Medical Journal, 2025, 53(9): 927-931.
|
| [3] |
ZHU Fangfang, LI Shida, CHEN Xiuying.
The therapeutic effect of Dangui Quyu Pill combined with acupuncture on adenomyosis
[J]. Tianjin Medical Journal, 2025, 53(7): 765-769.
|
| [4] |
DU Lingyun, WANG Yaowu, REN Nan.
Prognostic value of PRMT2, TRAF2 and metastasis-related gene in renal clear cell carcinoma
[J]. Tianjin Medical Journal, 2025, 53(5): 492-497.
|
| [5] |
WANG Chao, ZHANG Junmei, ZHANG Peng, LIU Li, WANG Xiaochun.
Comparison of efficacy of recombinant human interleukin-11 and herombopag olamine tablets on chemotherapy-induced thrombocytopenia in breast cancer
[J]. Tianjin Medical Journal, 2025, 53(4): 365-369.
|
| [6] |
LI Na, HE Ying, TENG Fei, HE Wenshu, GUO Caifeng, ZHONG Na, WU Qiong, LI Jun.
The application value of ultrasound BI-RADS classification combined with serum FGFR1 and GDF3 in the differential diagnosis of benign and malignant breast masses
[J]. Tianjin Medical Journal, 2025, 53(3): 247-251.
|
| [7] |
WANG Wei, XIA Haishui, MA Shang.
Efficacy of trastuzumab combined with neratinib in the treatment of HER-2 positive metastatic breast cancer
[J]. Tianjin Medical Journal, 2025, 53(3): 321-325.
|
| [8] |
WANG Linna, WANG Di, DONG Yanhong.
Clinical effect of aribulin combined with NP regimen in the treatment of patients with advanced breast cancer
[J]. Tianjin Medical Journal, 2025, 53(3): 326-330.
|
| [9] |
GAO Danqing, MA Xiaofeng, QIAN Yingjie, PEI Xiaomei, WANG Kaiwen.
Study on the correlation between serum SACE, MMP-9 and HPT with pulmonary infection in patients with schizophrenia
[J]. Tianjin Medical Journal, 2025, 53(2): 176-179.
|
| [10] |
HUANG Xiaoqing, LIU Yuanyuan, YAN Liang, YI Shuping.
Dosimetric comparison of two irradiation modes after radical mastectomy for breast cancer
[J]. Tianjin Medical Journal, 2025, 53(11): 1204-1207.
|
| [11] |
LIU Yuanyuan, HUANG Xiaoqing, YAN Liang, YI Shuping.
Preventive efficacy of rhGM-CSF combined with Kangfuxin liquid on radiation dermatitis of breast cancer
[J]. Tianjin Medical Journal, 2025, 53(10): 1076-1080.
|
| [12] |
MAN Yi, XU Ya, HE Xiancheng, SONG Shaofeng, LIU Aiguo.
Relationship between expression levels of EGFR, Ki-67, P53 and CTC and the prognosis of triple negative breast cancer
[J]. Tianjin Medical Journal, 2024, 52(8): 862-867.
|
| [13] |
ZHU Gangming, DONG Yongde, ZHU Ruiting, TAN Yuanman, TAO Juan, LIU Xiao, CHEN Decheng, YANG Gai.
The value of magnetic resonance relaxation time quantitative imaging in predicting molecular subtypes of invasive ductal carcinoma
[J]. Tianjin Medical Journal, 2024, 52(7): 770-774.
|
| [14] |
CHEN Zhiyan, WU Qiuyuan, DENG Yuhua, ZHOU Dan.
Status and application of organoid technology in breast cancer research
[J]. Tianjin Medical Journal, 2024, 52(6): 668-672.
|
| [15] |
LIU Danyang, LI Yongtao, ZHANG Haiyan, LI Lin, LIU Yang, SHEN Lei.
Effect of breast cancer cell conditioned medium on biological behavior of bone marrow mesenchymal stem cells
[J]. Tianjin Medical Journal, 2024, 52(5): 454-458.
|